Navigation Links
Microsoft's Surface Pro Tablet Makes its Debut and Sells Out Fast; the Company was One of the Few to Defy the Dow's Loss Yesterday
Date:2/12/2013

NEW YORK, February 12, 2013 /PRNewswire/ --

MSFT shares saw a 1.13% gain on Monday after the Company's Surface Pro tablet was launched over this past weekend. The Surface Pro sold out even though reviews were mixed on it. The Company was one of the few to defy the Dow's loss yesterday.

Whether bull or bear The Stock Freak has got you covered! Sign up to receive our free newsletters and stay up to date with stocks on the run. http://www.TheStockFreak.com    

Annaly Capital Management, Inc. (NYSE: NLY) - NLY traded on volume more than double the stock's average on Monday with little change in price at the close. The stock saw a slight gain of 9 cents to close at $14.81. Annaly was one of the most active stocks to trade on the NYSE yesterday. The Company reported last week that GAAP net income for the fourth quarter of 2012 was $700.5 million or $0.70 per share, compared to $445.6 million or $0.46 per share for the same quarter the prior year. Shares of NLY were trading over $17 last September. Annaly Capital Management, Inc., a real estate investment trust, engages in the ownership, management, and financing of a portfolio of investment securities.

Zynga, Inc. (Nasdaq: ZNGA) - Trading volume for Zynga on Monday was more than four times higher than usual. The stock traded 98,777,816 shares in comparison to an average of 22,875,900. The stock was one of the most active stocks traded on the Nasdaq yesterday. Earlier this month shares of Zynga were trading at $2.67. The stock closed at 3.67 yesterday, up 7%. The Company's CRO sold 28,847 shares on January 24th and 86,541 shares on January 28th. Zynga Inc. develops, markets, and operates online social games as live services on the Internet, social networking sites, and mobile platforms.

Novo Nordisk A/S (NYSE: NVO) - NVO shares dropped yesterday after the U.S. Food and Drug Administration asked for further testing on the treatments of the Company's new insulin products. Novo said they won't be able to complete the request this year. Volume on Monday was significantly higher than average at 2,267,599 shares traded. The stock closed at 165.40, down 13.98%. Analysts polled by FactSet are calling for Novo Nordisk to earn $8.38 a share for the year. Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products in Denmark and internationally.

Zion Oil & Gas, Inc. (Nasdaq: ZN) - Zion Oil & Gas was one of the biggest gainers on the Nasdaq yesterday. The stock saw unusually high trading volume on Monday, and closed up 27.21% at $1.59. Volume traded was more than ten times higher than usual at 1,412,630 shares. ZN was trading as low as $0.81 at the end of January. On Monday the stock saw an intra-day high of $1.75, representing gains of over 100%. Zion Oil & Gas, Inc. operates as a development stage oil and gas exploration company in Israel.

ModusLink Global Solutions, Inc. (Nasdaq: MLNK) - MLNK soared as much as 20% on Monday when it hit an intra-day high of $3.40. Yesterday morning news came out announcing that New York-based Steel Partners Holdings L.P. will invest $30 million in return for several changes to ModusLink's board of directors. Under the terms of the agreement, Steel Holdings would purchase 7.5 million newly issued shares of common stock at a price of $4.00 per share, representing a cash investment in the Company, before fees and expenses, of $30 million.  Shares of ModusLink closed at 3.13 on Monday, up 13.82%. Volume traded at 1,044,856 shares was roughly five times higher than the stock's average of 195,987 shares.

To find similar research reports that are available for free follow the link below and sign up at http://www.TheStockFreak.com

Disclosure: TheStockFreak.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.


'/>"/>
SOURCE www.thestockfreak.com
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Arthrosurface Hits a $100 Million Milestone
2. PDI Signs Agreement with HealthTrust for Surface Disinfection Products
3. Apollo Hospitals Perform Revolutionary Minimally Invasive Knee Replacement (Resurfacement) Surgery
4. Mylan Launches Generic Version of Zyprexa® Tablets
5. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
6. Mylan Launches Generic Version of Plavix® Tablets
7. Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)
8. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
9. Mylan Launches Generic Version of Viramune® Tablets
10. Mylan Launches Generic Version of Bonviva® Film Coated Tablets in the UK and Italy
11. FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... The Mobile X-Ray product segment is the most attractive market ... period Mobile X-Ray segment is the largest segment ... market, which is estimated to be valued at more than ... 7% over the forecast period. Mobile X-Ray segment is expected ... Mn in 2017 over 2016. The segment,s revenue in the ...
(Date:4/19/2017)... 2017 Global Prostate Cancer Therapeutics Market: ... prostate cancer therapeutics market analyzes the current and ... of prostate cancer, launch of promising emerging therapies, ... new drugs & therapeutic biological products, and high ... lesser side effects are some of the drivers ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
Breaking Medicine Technology:
(Date:4/28/2017)... LINCOLN, R.I. (PRWEB) , ... April 28, 2017 , ... Getting enough sleep affects much ... Sleep Foundation (NSF), going just 19 hours without sleep can compromise motor reaction time, which ... Awareness Week, and Amica Insurance is sharing the following tips from the NSF to help ...
(Date:4/28/2017)... ... April 28, 2017 , ... Date aired: ... , “Computers are everywhere and they’re here to stay,” said Sharon Kleyne on ... and Your Health on Voice America sponsored by Nature’s Tears® EyeMist®. So she ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Radiology Business Management Association (RBMA) ... 2017-2018. The annual board election process has been in place since the RBMA was ... C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... ... April 28, 2017 , ... From ... College of Urgent Care Medicine will host industry leaders for the annual spring ... help those in the industry adapt to the issues currently affecting urgent care ...
Breaking Medicine News(10 mins):